New NCI Director Plans Greater Support For Translational Research, Collaboration.
HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.
French Legion d’Honneur Bestowed On Hortobagyi.
Mammography Summit Planned For June In Milan.
Urgent Need For New Drugs To Treat Pre-Cancers: AACR.
Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.
FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.
American Home Products Changes Name To Wyeth.
Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- In the Headlines: “There’s no one to stand up for NCI right now.”
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - $180M in NCI grants have been terminated by Trump administration, systematic review finds